Filter
510
Featured
82
87
Language
Document type
185
98
71
57
32
24
16
9
8
5
5
Countries
85
71
59
57
24
21
21
19
19
18
17
16
15
14
13
12
9
9
9
8
8
8
7
7
6
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
268
23
22
22
12
9
3
Toolboxes
201
35
33
29
28
23
10
7
7
7
6
6
5
5
4
4
3
3
1
1
1
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la prévention et le traitement
...
Mars 2020. Recommendations selon les differentes phases
This guidance covers diagnosis and care of patients with long-term effects of COVID-19. It makes recommendations for the care of adults and children who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It is meant for health and care practitioners. This interim documen
...
27 May 2021
This is a document to support the use of pulse oximeter for assessment of suspected and confirmed cases of Covid-19 in the community.
It is a well-known fact that Covid-19 can present as “happy hypoxia” with minimum symptoms of severe respiratory distress despite significant low ox
...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO a
...
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Ta
...
Revised COVID-19 Testing Strategy
recommended
Second edition. June 2022. This revised guidance recommends that access to COVID-19 testing is decentralized as far as possible and made available at health facilities, and through the use of self tests to enable access to care and the mitigation of transmission. Testing should be prioritized for hi
...
Accessed: 31.03.2020
Accessed: 01.04.2020
Accessed: 02.04.2020
Accessed: 02.04.2020
Accessed: 02.04.2020
Accessed: 02.04.2020
Available in English, French and Arabic
